Cargando…
Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer
Pancreatic cancer is an aggressive cancer, making it a leading cause of cancer-related deaths. It is characteristically resistant to treatment, which results in low survival rates. In pancreatic cancer, immune cells undergo transitions that can inhibit or promote their functions, enabling treatment...
Autores principales: | Elebo, Nnenna, Fru, Pascaline, Omoshoro-Jones, Jones, Candy, Geoffrey Patrick, Nweke, Ekene Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646946/ https://www.ncbi.nlm.nih.gov/pubmed/33174057 http://dx.doi.org/10.3892/mmr.2020.11622 |
Ejemplares similares
-
Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry
por: Elebo, Nnenna, et al.
Publicado: (2021) -
Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
por: Xelwa, Ntombikayise, et al.
Publicado: (2021) -
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
por: Elebo, Nnenna, et al.
Publicado: (2023) -
Chemokine receptor 8 expression may be linked to disease severity and elevated interleukin 6 secretion in acute pancreatitis
por: Nalisa, Mwangala, et al.
Publicado: (2021) -
SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways
por: Nweke, Ekene Emmanuel, et al.
Publicado: (2020)